EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 123 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.39 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $306,000 | -32.7% | 3,854 | -40.7% | 0.01% | -36.4% |
| Q3 2016 | $455,000 | +80.6% | 6,500 | 0.0% | 0.01% | +83.3% |
| Q2 2016 | $252,000 | -4.2% | 6,500 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $263,000 | -54.3% | 6,500 | 0.0% | 0.01% | -60.0% |
| Q4 2015 | $576,000 | +19.8% | 6,500 | 0.0% | 0.02% | +7.1% |
| Q3 2015 | $481,000 | -25.7% | 6,500 | -18.8% | 0.01% | -17.6% |
| Q2 2015 | $647,000 | +93.1% | 8,000 | 0.0% | 0.02% | +88.9% |
| Q1 2015 | $335,000 | – | 8,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 400,000 | $5,732,000 | 1.52% |
| Park West Asset Management LLC | 426,900 | $6,117,000 | 0.80% |
| WALL STREET ASSOCIATES | 200,000 | $2,866,000 | 0.25% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 284,653 | $4,079,000 | 0.16% |
| FARALLON CAPITAL MANAGEMENT LLC | 100,000 | $1,433,000 | 0.02% |
| NEXT Financial Group, Inc | 2,500 | $26,000 | 0.01% |
| PIPER SANDLER & CO. | 1,277 | $18,000 | 0.01% |
| Ground Swell Capital, LLC | 400 | $6,000 | 0.01% |
| PARADIGM ASSET MANAGEMENT CO LLC | 6,300 | $90,279,000 | 0.01% |
| Paloma Partners Management Co | 14,363 | $206,000 | 0.01% |